Miller, M AKane, M2000-04-062009-05-302000-04-062009-05-302000-04-06Miller MA, Kane M. Routine hepatitis B immunisation in India: cost-effectiveness assessment. Indian Journal of Pediatrics. 2000 Apr; 67(4): 299-300http://imsear.searo.who.int/handle/123456789/81723Based on World Bank guidelines, hepatitis B immunization would be an excellent public health investment, saving each life year for well below the per-capita gross domestic product. This would be one of the most cost-effective investments India could make in the field of health.engChildCost-Benefit AnalysisHepatitis B Vaccines --economicsHumansImmunization ProgramsIndiaJournal Article